Exploring low‐dose glucagon for exercise‐induced hypoglycaemia in type 1 diabetes: A randomised controlled trial

Documenti analoghi

• Is low‐dose glucagon needed and effective in preventing fasted exercise‐induced hypoglycaemia in type 1 diabetes treated with the MiniMed 780G , an automated insulin delivery system?
  di: Sissel Banner Lundemose, et al.
  Pubblicazione: (2024)
• Post‐exercise glycaemic control for 24 h: Fasted morning exercise with and without glucagon in adults with type 1 diabetes using automated insulin delivery
  di: Clara Solà, et al.
  Pubblicazione: (2025)
• Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial
  di: Ajenthen G. Ranjan, et al.
  Pubblicazione: (2026)
• Faster‐acting insulin aspart versus insulin aspart for adults with type 1 diabetes treated with non‐automated insulin pump and continuous glucose monitoring—A double‐blind randomized controlled crossover trial
  di: Ajenthen G. Ranjan, et al.
  Pubblicazione: (2025)
• Sensor‐derived glycaemic metrics in pregnant women with type 1 diabetes randomised to faster acting insulin aspart or insulin aspart—A secondary analysis of the CopenFast trial
  di: Julie C. Søholm, et al.
  Pubblicazione: (2024)